+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Anti-Radiation Drugs Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2023 to 2031

  • PDF Icon

    Report

  • 110 Pages
  • March 2024
  • Region: Global
  • Acute Market Reports
  • ID: 5949281
Description Jump to:
The 'anti-radiation drugs market' is expected to grow at a CAGR of 10.1% during the forecast period of 2024 to 2032, driven by the increasing prevalence of radiation exposure and the demand for effective therapeutic interventions. While distribution challenges present a notable constraint, the market's dynamic nature is evident in the distinct roles of compounds and applications.

As North America leads in revenue and Asia-Pacific emerges as a growth hub, strategic initiatives by key players underscore the collaborative efforts shaping the market's trajectory. The imperative for overcoming distribution challenges and advancing therapeutic applications positions the anti-radiation drugs market on a path of continuous evolution and innovation.

Key Market Drivers

Potassium Iodide (KI) Driving Market Growth

Potassium Iodide (KI) stands as a pivotal driver in the anti-radiation drugs market. With its well-established role in thyroid protection during radiation emergencies, KI has witnessed increased adoption worldwide. Evidence supporting this driver includes the widespread distribution of KI tablets by government agencies for public use in the event of nuclear accidents. For instance, the U.S. Nuclear Regulatory Commission recommends the use of KI as a thyroid-blocking agent during radiological emergencies, underscoring its significance in radiation protection.

Expanding Applications in Cancer Treatment

The expanding applications of anti-radiation drugs in cancer treatment contribute significantly to market growth. Prussian Blue, known for its efficacy in treating internal contamination with radioactive cesium and thallium, exemplifies this driver. The evidence lies in the clinical use of Prussian Blue to enhance the elimination of radioactive isotopes in patients, minimizing radiation exposure and improving therapeutic outcomes. The adoption of anti-radiation drugs as adjuncts to cancer therapy reflects their evolving role beyond emergency situations.

Increasing Preparedness for Nuclear Events

The global increase in preparedness for nuclear events acts as a key driver for the anti-radiation drugs market. Diethylenetriamine Pentaacetate (DTPA) and other chelating agents play a crucial role in treating individuals exposed to radioactive materials. The evidence supporting this driver includes the inclusion of DTPA in emergency response plans and medical countermeasures to address radiological incidents. Governments and healthcare institutions worldwide are actively enhancing their capabilities to respond to nuclear emergencies, fostering the demand for anti-radiation drugs.

Challenges in Distribution Channels

A significant restraint in the anti-radiation drugs market is associated with challenges in distribution channels. Despite the critical nature of these drugs, their availability in various distribution channels poses logistical challenges. Evidence supporting this constraint includes the limited accessibility of anti-radiation drugs in retail pharmacies and other outlets, hindering swift access for individuals in need. Overcoming these distribution challenges is crucial to ensuring timely and widespread availability during radiation emergencies.

Market Segmentation Analysis

Market by Compound: Potassium Iodide (KI) Dominates the Market

In 2023, Potassium Iodide (KI) emerged as the revenue leader, driven by its widespread use in radiation emergencies. Simultaneously, DTPA exhibited the highest CAGR, underscoring its increasing adoption for treating individuals exposed to radioactive materials. The evidence lies in the distinct roles these compounds play - KI for thyroid protection and DTPA for chelation therapy, demonstrating the market's dynamic nature and diverse applications.

Market by Application: ARS Dominates the Market

The market segmentation by application showcased ARS as the revenue leader in 2023, emphasizing the crucial role of anti-radiation drugs in addressing acute radiation effects. However, the Cancer Treatment segment exhibited the highest CAGR, indicating the growing utilization of these drugs in therapeutic settings. The evidence supporting this lies in clinical studies and advancements in cancer treatment protocols that incorporate anti-radiation drugs.

Market by Distribution Channel: Hospital Pharmacies Dominate the Market

Hospital Pharmacies led in both revenue and CAGR in 2023, emphasizing the pivotal role of healthcare institutions in dispensing anti-radiation drugs. The evidence lies in the specialized nature of these drugs, requiring expert guidance and oversight. Retail Pharmacies, while contributing to accessibility, exhibited a lower CAGR, reflecting the challenges in distributing specialized medications through traditional retail channels.

North America Remains the Global Leader

  • North America
  • UK and European Union
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Key Questions Answered

  • What are the key micro and macro environmental factors that are impacting the growth of Anti-Radiation Drugs market?
  • What are the key investment pockets with respect to product segments and geographies currently and during the forecast period?
  • Estimated forecast and market projections up to 2031.
  • Which segment accounts for the fastest CAGR during the forecast period?
  • Which market segment holds a larger market share and why?
  • Are low and middle-income economies investing in the Anti-Radiation Drugs market?
  • Which is the largest regional market for Anti-Radiation Drugs market?
  • What are the market trends and dynamics in emerging markets such as Asia Pacific, Latin America, and Middle East & Africa?
  • Which are the key trends driving Anti-Radiation Drugs market growth?
  • Who are the key competitors and what are their key strategies to enhance their market presence in the Anti-Radiation Drugs market worldwide?


This product will be delivered within 2 business days.

Table of Contents

1. Preface
1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. Key Offerings
1.2. Market Segmentation
1.3. Research Methodology
1.3.1. Phase I - Secondary Research
1.3.2. Phase II - Primary Research
1.3.3. Phase III - Expert Panel Review
1.3.4. Assumptions
1.3.5. Approach Adopted
2. Executive Summary
2.1. Market Snapshot: Global Anti-Radiation Drugs Market
2.2. Global Anti-Radiation Drugs Market, By Compound, 2023 (US$ Million)
2.3. Global Anti-Radiation Drugs Market, By Application, 2023 (US$ Million)
2.4. Global Anti-Radiation Drugs Market, By Distribution Channel, 2023 (US$ Million)
2.5. Global Anti-Radiation Drugs Market, By Geography, 2023 (US$ Million)
2.6. Attractive Investment Proposition by Geography, 2023
3. Anti-Radiation Drugs Market: Competitive Analysis
3.1. Market Positioning of Key Anti-Radiation Drugs Market Vendors
3.2. Strategies Adopted by Anti-Radiation Drugs Market Vendors
3.3. Key Industry Strategies
3.4. Tier Analysis 2023 Versus 2032
4. Anti-Radiation Drugs Market: Macro Analysis & Market Dynamics
4.1. Introduction
4.2. Global Anti-Radiation Drugs Market Value, 2022 - 2032, (US$ Million)
4.3. Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Key Challenges
4.3.4. Key Opportunities
4.4. Impact Analysis of Drivers and Restraints
4.5. See-Saw Analysis
4.6. Porter's Five Force Model
4.6.1. Supplier Power
4.6.2. Buyer Power
4.6.3. Threat of Substitutes
4.6.4. Threat of New Entrants
4.6.5. Competitive Rivalry
4.7. PESTEL Analysis
4.7.1. Political Landscape
4.7.2. Economic Landscape
4.7.3. Technology Landscape
4.7.4. Legal Landscape
4.7.5. Social Landscape
5. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
5.1. Market Overview
5.2. Growth & Revenue Analysis: 2023 Versus 2032
5.3. Market Segmentation
5.3.1. Potassium Iodide (KI)
5.3.2. Prussian Blue
5.3.3. DTPA (Diethylenetriamine Pentaacetate)
5.3.4. Others
6. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
6.1. Market Overview
6.2. Growth & Revenue Analysis: 2023 Versus 2032
6.3. Market Segmentation
6.3.1. Acute Radiation Syndrome (ARS)
6.3.2. Cancer Treatment
6.3.3. Radiation Exposure
6.3.4. Others
7. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
7.1. Market Overview
7.2. Growth & Revenue Analysis: 2023 Versus 2032
7.3. Market Segmentation
7.3.1. Hospital Pharmacies
7.3.2. Retail Pharmacies
7.3.3. Others
8. North America Anti-Radiation Drugs Market, 2022-2032, USD (Million)
8.1. Market Overview
8.2. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
8.3. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
8.4. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
8.5. Anti-Radiation Drugs Market: By Region, 2022-2032, USD (Million)
8.5.1. North America
8.5.1.1. U.S.
8.5.1.1.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
8.5.1.1.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
8.5.1.1.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
8.5.1.2. Canada
8.5.1.2.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
8.5.1.2.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
8.5.1.2.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
8.5.1.3. Rest of North America
8.5.1.3.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
8.5.1.3.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
8.5.1.3.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
9. UK and European Union Anti-Radiation Drugs Market, 2022-2032, USD (Million)
9.1. Market Overview
9.2. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
9.3. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
9.4. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
9.5. Anti-Radiation Drugs Market: By Region, 2022-2032, USD (Million)
9.5.1. UK and European Union
9.5.1.1. UK
9.5.1.1.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
9.5.1.1.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
9.5.1.1.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
9.5.1.2. Germany
9.5.1.2.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
9.5.1.2.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
9.5.1.2.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
9.5.1.3. Spain
9.5.1.3.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
9.5.1.3.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
9.5.1.3.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
9.5.1.4. Italy
9.5.1.4.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
9.5.1.4.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
9.5.1.4.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
9.5.1.5. France
9.5.1.5.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
9.5.1.5.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
9.5.1.5.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
9.5.1.6. Rest of Europe
9.5.1.6.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
9.5.1.6.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
9.5.1.6.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
10. Asia Pacific Anti-Radiation Drugs Market, 2022-2032, USD (Million)
10.1. Market Overview
10.2. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
10.3. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
10.4. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
10.5. Anti-Radiation Drugs Market: By Region, 2022-2032, USD (Million)
10.5.1. Asia Pacific
10.5.1.1. China
10.5.1.1.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
10.5.1.1.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
10.5.1.1.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
10.5.1.2. Japan
10.5.1.2.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
10.5.1.2.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
10.5.1.2.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
10.5.1.3. India
10.5.1.3.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
10.5.1.3.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
10.5.1.3.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
10.5.1.4. Australia
10.5.1.4.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
10.5.1.4.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
10.5.1.4.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
10.5.1.5. South Korea
10.5.1.5.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
10.5.1.5.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
10.5.1.5.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
10.5.1.6. Rest of Asia Pacific
10.5.1.6.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
10.5.1.6.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
10.5.1.6.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
11. Latin America Anti-Radiation Drugs Market, 2022-2032, USD (Million)
11.1. Market Overview
11.2. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
11.3. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
11.4. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
11.5. Anti-Radiation Drugs Market: By Region, 2022-2032, USD (Million)
11.5.1. Latin America
11.5.1.1. Brazil
11.5.1.1.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
11.5.1.1.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
11.5.1.1.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
11.5.1.2. Mexico
11.5.1.2.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
11.5.1.2.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
11.5.1.2.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
11.5.1.3. Rest of Latin America
11.5.1.3.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
11.5.1.3.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
11.5.1.3.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
12. Middle East and Africa Anti-Radiation Drugs Market, 2022-2032, USD (Million)
12.1. Market Overview
12.2. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
12.3. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
12.4. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
12.5. Anti-Radiation Drugs Market: By Region, 2022-2032, USD (Million)
12.5.1. Middle East and Africa
12.5.1.1. GCC
12.5.1.1.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
12.5.1.1.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
12.5.1.1.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
12.5.1.2. Africa
12.5.1.2.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
12.5.1.2.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
12.5.1.2.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
12.5.1.3. Rest of Middle East and Africa
12.5.1.3.1. Anti-Radiation Drugs Market: By Compound, 2022-2032, USD (Million)
12.5.1.3.2. Anti-Radiation Drugs Market: By Application, 2022-2032, USD (Million)
12.5.1.3.3. Anti-Radiation Drugs Market: By Distribution Channel, 2022-2032, USD (Million)
13. Company Profiles
13.1. Recipharm AB
13.1.1. Company Overview
13.1.2. Financial Performance
13.1.3. Product Portfolio
13.1.4. Strategic Initiatives
13.2. NukeRx
13.2.1. Company Overview
13.2.2. Financial Performance
13.2.3. Product Portfolio
13.2.4. Strategic Initiatives
13.3. Bausch Health Companies Inc
13.3.1. Company Overview
13.3.2. Financial Performance
13.3.3. Product Portfolio
13.3.4. Strategic Initiatives
13.4. Amgen Inc.
13.4.1. Company Overview
13.4.2. Financial Performance
13.4.3. Product Portfolio
13.4.4. Strategic Initiatives
13.5. Anbex Inc.
13.5.1. Company Overview
13.5.2. Financial Performance
13.5.3. Product Portfolio
13.5.4. Strategic Initiatives
13.6. Arco Pharmaceuticals LLC
13.6.1. Company Overview
13.6.2. Financial Performance
13.6.3. Product Portfolio
13.6.4. Strategic Initiatives
13.7. BTG International Inc.
13.7.1. Company Overview
13.7.2. Financial Performance
13.7.3. Product Portfolio
13.7.4. Strategic Initiatives
13.8. Cellphire, Inc.
13.8.1. Company Overview
13.8.2. Financial Performance
13.8.3. Product Portfolio
13.8.4. Strategic Initiatives
13.9. Chrysalis BioTherapeutics, Inc.
13.9.1. Company Overview
13.9.2. Financial Performance
13.9.3. Product Portfolio
13.9.4. Strategic Initiatives
13.10. Darnitsa
13.10.1. Company Overview
13.10.2. Financial Performance
13.10.3. Product Portfolio
13.10.4. Strategic Initiatives
13.11. Enzychem Lifesciences Corporation
13.11.1. Company Overview
13.11.2. Financial Performance
13.11.3. Product Portfolio
13.11.4. Strategic Initiatives
13.12. Humanetics Corporation
13.12.1. Company Overview
13.12.2. Financial Performance
13.12.3. Product Portfolio
13.12.4. Strategic Initiatives
13.13. Mission Pharmacal Company
13.13.1. Company Overview
13.13.2. Financial Performance
13.13.3. Product Portfolio
13.13.4. Strategic Initiatives
13.14. Myelo Therapeutics GmbH
13.14.1. Company Overview
13.14.2. Financial Performance
13.14.3. Product Portfolio
13.14.4. Strategic Initiatives
13.15. Partner Therapeutics
13.15.1. Company Overview
13.15.2. Financial Performance
13.15.3. Product Portfolio
13.15.4. Strategic Initiatives
13.16. Pluri Inc.
13.16.1. Company Overview
13.16.2. Financial Performance
13.16.3. Product Portfolio
13.16.4. Strategic Initiatives
13.17. Other Notable Players
13.17.1. Company Overview
13.17.2. Financial Performance
13.17.3. Product Portfolio
13.17.4. Strategic Initiatives
List of Figures
Figure 1 Global Anti-Radiation Drugs Market: Market Coverage
Figure 2 Research Methodology and Data Sources
Figure 3 Market Size Estimation - Top Down & Bottom-Up Approach
Figure 4 Global Anti-Radiation Drugs Market: Quality Assurance
Figure 5 Global Anti-Radiation Drugs Market, By Compound, 2023
Figure 6 Global Anti-Radiation Drugs Market, By Application, 2023
Figure 7 Global Anti-Radiation Drugs Market, By Distribution Channel, 2023
Figure 8 Global Anti-Radiation Drugs Market, By Geography, 2023
Figure 9 Market Geographical Opportunity Matrix - Global Anti-Radiation Drugs Market, 2023
Figure 10 Market Positioning of Key Anti-Radiation Drugs Market Players, 2023
Figure 11 Global Anti-Radiation Drugs Market - Tier Analysis - Percentage of Revenues by Tier Level, 2023 Versus 2032
Figure 12 Global Anti-Radiation Drugs Market, By Compound, 2023 Vs 2032, %
Figure 13 Global Anti-Radiation Drugs Market, By Application, 2023 Vs 2032, %
Figure 14 Global Anti-Radiation Drugs Market, By Distribution Channel, 2023 Vs 2032, %
Figure 15 U.S. Anti-Radiation Drugs Market (US$ Million), 2022 - 2032
Figure 16 Canada Anti-Radiation Drugs Market (US$ Million), 2022 - 2032
Figure 17 Rest of North America Anti-Radiation Drugs Market (US$ Million), 2022 - 2032
Figure 18 UK Anti-Radiation Drugs Market (US$ Million), 2022 - 2032
Figure 19 Germany Anti-Radiation Drugs Market (US$ Million), 2022 - 2032
Figure 20 Spain Anti-Radiation Drugs Market (US$ Million), 2022 - 2032
Figure 21 Italy Anti-Radiation Drugs Market (US$ Million), 2022 - 2032
Figure 22 France Anti-Radiation Drugs Market (US$ Million), 2022 - 2032
Figure 23 Rest of Europe Anti-Radiation Drugs Market (US$ Million), 2022 - 2032
Figure 24 China Anti-Radiation Drugs Market (US$ Million), 2022 - 2032
Figure 25 Japan Anti-Radiation Drugs Market (US$ Million), 2022 - 2032
Figure 26 India Anti-Radiation Drugs Market (US$ Million), 2022 - 2032
Figure 27 Australia Anti-Radiation Drugs Market (US$ Million), 2022 - 2032
Figure 28 South Korea Anti-Radiation Drugs Market (US$ Million), 2022 - 2032
Figure 29 Rest of Asia Anti-Radiation Drugs Market (US$ Million), 2022 - 2032
Figure 30 Brazil Anti-Radiation Drugs Market (US$ Million), 2022 - 2032
Figure 31 Mexico Anti-Radiation Drugs Market (US$ Million), 2022 - 2032
Figure 32 Rest of Latin America Anti-Radiation Drugs Market (US$ Million), 2022 - 2032
Figure 33 GCC Anti-Radiation Drugs Market (US$ Million), 2022 - 2032
Figure 34 Africa Anti-Radiation Drugs Market (US$ Million), 2022 - 2032
Figure 35 Rest of Middle East and Africa Anti-Radiation Drugs Market (US$ Million), 2022 - 2032
List of Tables
Table 1 Global Anti-Radiation Drugs Market by Compound, 2022-2032, USD (Million)
Table 2 Global Anti-Radiation Drugs Market by Application, 2022-2032, USD (Million)
Table 3 Global Anti-Radiation Drugs Market by Distribution Channel, 2022-2032, USD (Million)
Table 4 North America Anti-Radiation Drugs Market by Compound, 2022-2032, USD (Million)
Table 5 North America Anti-Radiation Drugs Market by Application, 2022-2032, USD (Million)
Table 6 North America Anti-Radiation Drugs Market by Distribution Channel, 2022-2032, USD (Million)
Table 7 U.S. Anti-Radiation Drugs Market by Compound, 2022-2032, USD (Million)
Table 8 U.S. Anti-Radiation Drugs Market by Application, 2022-2032, USD (Million)
Table 9 U.S. Anti-Radiation Drugs Market by Distribution Channel, 2022-2032, USD (Million)
Table 10 Canada Anti-Radiation Drugs Market by Compound, 2022-2032, USD (Million)
Table 11 Canada Anti-Radiation Drugs Market by Application, 2022-2032, USD (Million)
Table 12 Canada Anti-Radiation Drugs Market by Distribution Channel, 2022-2032, USD (Million)
Table 13 Rest of North America Anti-Radiation Drugs Market by Compound, 2022-2032, USD (Million)
Table 14 Rest of North America Anti-Radiation Drugs Market by Application, 2022-2032, USD (Million)
Table 15 Rest of North America Anti-Radiation Drugs Market by Distribution Channel, 2022-2032, USD (Million)
Table 16 UK and European Union Anti-Radiation Drugs Market by Compound, 2022-2032, USD (Million)
Table 17 UK and European Union Anti-Radiation Drugs Market by Application, 2022-2032, USD (Million)
Table 18 UK and European Union Anti-Radiation Drugs Market by Distribution Channel, 2022-2032, USD (Million)
Table 19 UK Anti-Radiation Drugs Market by Compound, 2022-2032, USD (Million)
Table 20 UK Anti-Radiation Drugs Market by Application, 2022-2032, USD (Million)
Table 21 UK Anti-Radiation Drugs Market by Distribution Channel, 2022-2032, USD (Million)
Table 22 Germany Anti-Radiation Drugs Market by Compound, 2022-2032, USD (Million)
Table 23 Germany Anti-Radiation Drugs Market by Application, 2022-2032, USD (Million)
Table 24 Germany Anti-Radiation Drugs Market by Distribution Channel, 2022-2032, USD (Million)
Table 25 Spain Anti-Radiation Drugs Market by Compound, 2022-2032, USD (Million)
Table 26 Spain Anti-Radiation Drugs Market by Application, 2022-2032, USD (Million)
Table 27 Spain Anti-Radiation Drugs Market by Distribution Channel, 2022-2032, USD (Million)
Table 28 Italy Anti-Radiation Drugs Market by Compound, 2022-2032, USD (Million)
Table 29 Italy Anti-Radiation Drugs Market by Application, 2022-2032, USD (Million)
Table 30 Italy Anti-Radiation Drugs Market by Distribution Channel, 2022-2032, USD (Million)
Table 31 France Anti-Radiation Drugs Market by Compound, 2022-2032, USD (Million)
Table 32 France Anti-Radiation Drugs Market by Application, 2022-2032, USD (Million)
Table 33 France Anti-Radiation Drugs Market by Distribution Channel, 2022-2032, USD (Million)
Table 34 Rest of Europe Anti-Radiation Drugs Market by Compound, 2022-2032, USD (Million)
Table 35 Rest of Europe Anti-Radiation Drugs Market by Application, 2022-2032, USD (Million)
Table 36 Rest of Europe Anti-Radiation Drugs Market by Distribution Channel, 2022-2032, USD (Million)
Table 37 Asia Anti-Radiation Drugs Market by Compound, 2022-2032, USD (Million)
Table 38 Asia Anti-Radiation Drugs Market by Application, 2022-2032, USD (Million)
Table 39 Asia Anti-Radiation Drugs Market by Distribution Channel, 2022-2032, USD (Million)
Table 40 China Anti-Radiation Drugs Market by Compound, 2022-2032, USD (Million)
Table 41 China Anti-Radiation Drugs Market by Application, 2022-2032, USD (Million)
Table 42 China Anti-Radiation Drugs Market by Distribution Channel, 2022-2032, USD (Million)
Table 43 Japan Anti-Radiation Drugs Market by Compound, 2022-2032, USD (Million)
Table 44 Japan Anti-Radiation Drugs Market by Application, 2022-2032, USD (Million)
Table 45 Japan Anti-Radiation Drugs Market by Distribution Channel, 2022-2032, USD (Million)
Table 46 India Anti-Radiation Drugs Market by Compound, 2022-2032, USD (Million)
Table 47 India Anti-Radiation Drugs Market by Application, 2022-2032, USD (Million)
Table 48 India Anti-Radiation Drugs Market by Distribution Channel, 2022-2032, USD (Million)
Table 49 Australia Anti-Radiation Drugs Market by Compound, 2022-2032, USD (Million)
Table 50 Australia Anti-Radiation Drugs Market by Application, 2022-2032, USD (Million)
Table 51 Australia Anti-Radiation Drugs Market by Distribution Channel, 2022-2032, USD (Million)
Table 52 South Korea Anti-Radiation Drugs Market by Compound, 2022-2032, USD (Million)
Table 53 South Korea Anti-Radiation Drugs Market by Application, 2022-2032, USD (Million)
Table 54 South Korea Anti-Radiation Drugs Market by Distribution Channel, 2022-2032, USD (Million)
Table 55 Latin America Anti-Radiation Drugs Market by Compound, 2022-2032, USD (Million)
Table 56 Latin America Anti-Radiation Drugs Market by Application, 2022-2032, USD (Million)
Table 57 Latin America Anti-Radiation Drugs Market by Distribution Channel, 2022-2032, USD (Million)
Table 58 Brazil Anti-Radiation Drugs Market by Compound, 2022-2032, USD (Million)
Table 59 Brazil Anti-Radiation Drugs Market by Application, 2022-2032, USD (Million)
Table 60 Brazil Anti-Radiation Drugs Market by Distribution Channel, 2022-2032, USD (Million)
Table 61 Mexico Anti-Radiation Drugs Market by Compound, 2022-2032, USD (Million)
Table 62 Mexico Anti-Radiation Drugs Market by Application, 2022-2032, USD (Million)
Table 63 Mexico Anti-Radiation Drugs Market by Distribution Channel, 2022-2032, USD (Million)
Table 64 Rest of Latin America Anti-Radiation Drugs Market by Compound, 2022-2032, USD (Million)
Table 65 Rest of Latin America Anti-Radiation Drugs Market by Application, 2022-2032, USD (Million)
Table 66 Rest of Latin America Anti-Radiation Drugs Market by Distribution Channel, 2022-2032, USD (Million)
Table 67 Middle East and Africa Anti-Radiation Drugs Market by Compound, 2022-2032, USD (Million)
Table 68 Middle East and Africa Anti-Radiation Drugs Market by Application, 2022-2032, USD (Million)
Table 69 Middle East and Africa Anti-Radiation Drugs Market by Distribution Channel, 2022-2032, USD (Million)
Table 70 GCC Anti-Radiation Drugs Market by Compound, 2022-2032, USD (Million)
Table 71 GCC Anti-Radiation Drugs Market by Application, 2022-2032, USD (Million)
Table 72 GCC Anti-Radiation Drugs Market by Distribution Channel, 2022-2032, USD (Million)
Table 73 Africa Anti-Radiation Drugs Market by Compound, 2022-2032, USD (Million)
Table 74 Africa Anti-Radiation Drugs Market by Application, 2022-2032, USD (Million)
Table 75 Africa Anti-Radiation Drugs Market by Distribution Channel, 2022-2032, USD (Million)
Table 76 Rest of Middle East and Africa Anti-Radiation Drugs Market by Compound, 2022-2032, USD (Million)
Table 77 Rest of Middle East and Africa Anti-Radiation Drugs Market by Application, 2022-2032, USD (Million)
Table 78 Rest of Middle East and Africa Anti-Radiation Drugs Market by Distribution Channel, 2022-2032, USD (Million)

Companies Mentioned

  • Recipharm AB
  • NukeRx
  • Bausch Health Companies Inc
  • Amgen Inc.
  • Anbex Inc.
  • Arco Pharmaceuticals LLC
  • BTG International Inc.
  • Cellphire, Inc.
  • Chrysalis BioTherapeutics, Inc.
  • Darnitsa
  • Enzychem Lifesciences Corporation
  • Humanetics Corporation
  • Mission Pharmacal Company
  • Myelo Therapeutics GmbH
  • Partner Therapeutics
  • Pluri Inc.

Related Topics

Related Reports

Radiation Toxicity Treatment Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F - Product Image

Radiation Toxicity Treatment Market - Global Industry Size, Share, Trends Opportunity, and Forecast, 2028F

  • Report
  • 185 Pages
  • Global
From
Acute Radiation Syndrome - Pipeline Insight, 2024 - Product Image

Acute Radiation Syndrome - Pipeline Insight, 2024

  • Drug Pipelines
  • 40 Pages
  • Global
From
Radiation Toxicity - Pipeline Insight, 2024 - Product Image

Radiation Toxicity - Pipeline Insight, 2024

  • Clinical Trials
  • 60 Pages
  • Global
From
Anti Ageing Drugs Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Anti Ageing Drugs Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 84 Pages
  • Global
From
Squalene Market Report by Source Type (Animal, Vegetable, Synthetic), Application (Cosmetics, Food, Pharmaceuticals, and Others), and Region 2023-2028 - Product Image

Squalene Market Report by Source Type (Animal, Vegetable, Synthetic), Application (Cosmetics, Food, Pharmaceuticals, and Others), and Region 2023-2028

  • Report
  • 149 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.